Published in Neurology on October 26, 2010
Understanding the Pathophysiology of Migraine Pain | NCT03026101
Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci (2011) 1.71
Modulation of CGRP-induced light aversion in wild-type mice by a 5-HT(1B/D) agonist. J Neurosci (2012) 0.98
Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev (2014) 0.96
Comparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds. J Headache Pain (2014) 0.85
Antidromic vasodilatation and the migraine mechanism. J Headache Pain (2011) 0.85
Chemical mediators of migraine: preclinical and clinical observations. Headache (2011) 0.84
Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev (2017) 0.81
Blocking neurogenic inflammation for the treatment of acute disorders of the central nervous system. Int J Inflam (2013) 0.81
Neurovascular contributions to migraine: Moving beyond vasodilation. Neuroscience (2016) 0.80
Development of anti-migraine therapeutics using the capsaicin-induced dermal blood flow model. Br J Clin Pharmacol (2015) 0.79
Measurement precision and biological variation of cranial arteries using automated analysis of 3 T magnetic resonance angiography. J Headache Pain (2014) 0.79
Calcitonin Gene-Related Peptide Regulates Cardiomyocyte Survival through Regulation of Oxidative Stress by PI3K/Akt and MAPK Signaling Pathways. Ann Clin Exp Hypertens (2014) 0.78
Calcitonin Gene-Related Peptide Modulates Heat Nociception in the Human Brain - An fMRI Study in Healthy Volunteers. PLoS One (2016) 0.78
Effect of CGRP and sumatriptan on the BOLD response in visual cortex. J Headache Pain (2012) 0.77
Calcitonin gene-related peptide receptor antagonists and triptans: a tale of two treatments. Neurology (2010) 0.76
Effects of Voluntary Locomotion and Calcitonin Gene-Related Peptide on the Dynamics of Single Dural Vessels in Awake Mice. J Neurosci (2016) 0.75
Clinical importance of the middle meningeal artery: A review of the literature. Int J Med Sci (2016) 0.75
Pharmacological analysis of the increases in heart rate and diastolic blood pressure produced by (S)-isometheptene and (R)-isometheptene in pithed rats. J Headache Pain (2017) 0.75
Sumatriptan improves postoperative quality of recovery and reduces postcraniotomy headache after cranial nerve decompression. Br J Anaesth (2016) 0.75
Lack of migraine in headaches of familial dysautonomia patients. J Neural Transm (Vienna) (2012) 0.75
Cluster headache: present and future therapy. Neurol Sci (2017) 0.75
The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 9.40
New appendix criteria open for a broader concept of chronic migraine. Cephalalgia (2006) 5.97
Understanding the biologic basis of migraine. N Engl J Med (1994) 5.25
Epidemiology of headache in a general population--a prevalence study. J Clin Epidemiol (1991) 4.78
Autoregulation of brain circulation in severe arterial hypertension. Br Med J (1973) 4.11
Migraine headache is not associated with cerebral or meningeal vasodilatation--a 3T magnetic resonance angiography study. Brain (2008) 3.38
Evidence for a vascular factor in migraine. Ann Neurol (2011) 2.93
The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache. Cephalalgia (2005) 2.86
A yeast and a human CCAAT-binding protein have heterologous subunits that are functionally interchangeable. Cell (1988) 2.84
CGRP may play a causative role in migraine. Cephalalgia (2002) 2.40
Questionnaire versus clinical interview in the diagnosis of headache. Headache (1991) 2.36
Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia (1992) 2.33
Delayed hyperemia following hypoperfusion in classic migraine. Single photon emission computed tomographic demonstration. Arch Neurol (1988) 2.30
Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eighty-four male and female migraineurs from the general population. Cephalalgia (1996) 2.29
Regional cerebral blood flow in man determined by the initial slope of the clearance of intra-arterially injected 133Xe. Stroke (1974) 2.26
Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J Epidemiol Community Health (1992) 2.12
Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet (1991) 2.11
Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee. Neurology (2000) 2.10
Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol (1981) 2.03
Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia (2006) 2.01
Phosphorylation regulates in vivo interaction and molecular targeting of serine/arginine-rich pre-mRNA splicing factors. J Cell Biol (1999) 2.00
Symptomatic and nonsymptomatic headaches in a general population. Neurology (1992) 1.99
The genetic spectrum of a population-based sample of familial hemiplegic migraine. Brain (2006) 1.97
Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol (1995) 1.96
Increased familial risk and evidence of genetic factor in migraine. BMJ (1995) 1.96
A nosographic analysis of the migraine aura in a general population. Brain (1996) 1.91
Cerebral blood flow velocities are reduced during attacks of unilateral migraine without aura. Cephalalgia (1995) 1.82
Premonitory symptoms in migraine: an electronic diary study. Neurology (2003) 1.81
Multistage hybrid active appearance model matching: segmentation of left and right ventricles in cardiac MR images. IEEE Trans Med Imaging (2001) 1.69
Comparison of echocardiographic methods with magnetic resonance imaging for assessment of right ventricular function in children. Am J Cardiol (1995) 1.69
Improved description of the migraine aura by a diagnostic aura diary. Cephalalgia (1994) 1.68
Pressure-controlled palpation: a new technique which increases the reliability of manual palpation. Cephalalgia (1995) 1.64
Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs. Cephalalgia (1996) 1.62
Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS. Neurology (1998) 1.62
Monitoring tissue oxygen availability with near infrared spectroscopy (NIRS) in health and disease. Scand J Med Sci Sports (2001) 1.60
Subcutaneous sumatriptan during the migraine aura. Sumatriptan Aura Study Group. Neurology (1994) 1.59
Evidence of qualitatively altered nociception in patients with fibromyalgia. Arthritis Rheum (1997) 1.58
Presentation of a new instrument: the diagnostic headache diary. Cephalalgia (1992) 1.57
Muscle palpation with controlled finger pressure: new equipment for the study of tender myofascial tissues. Pain (1994) 1.54
Interrelations between migraine and tension-type headache in the general population. Arch Neurol (1992) 1.53
Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial. Lancet (1999) 1.52
Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensities. Stroke (2002) 1.50
Increased risk of migraine with typical aura in probands with familial hemiplegic migraine and their relatives. Eur J Neurol (2003) 1.49
Diagnosis and management of migraine. BMJ (1996) 1.47
Botulinum toxin in headache treatment: the end of the road? Cephalalgia (2006) 1.46
The effect of intracarotid epinephrine, norepinephrine, and angiotensin on the regional cerebral blood flow in man. Neurology (1972) 1.46
Calcitonin gene-related peptide (CGRP) levels during glyceryl trinitrate (GTN)-induced headache in healthy volunteers. Cephalalgia (2010) 1.45
Nitroglycerin-induced headache is not dependent on histamine release: support for a direct nociceptive action of nitric oxide. Cephalalgia (1994) 1.44
Possible mechanisms of action of nitric oxide synthase inhibitors in chronic tension-type headache. Brain (1999) 1.43
The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers. Cephalalgia (2005) 1.39
The International classification of headache disorders, 2nd edn (ICDH-II). J Neurol Neurosurg Psychiatry (2004) 1.39
Evaluation of pericranial myofascial nociception by pressure algometry. Reproducibility and factors of variation. Cephalalgia (1992) 1.39
Exteroceptive suppression of temporal muscle activity is normal in chronic tension-type headache and not related to actual headache state. Cephalalgia (1996) 1.39
Myofibre damage in human skeletal muscle: effects of electrical stimulation versus voluntary contraction. J Physiol (2007) 1.38
[Are psychiatric diseases brain diseases?]. Ugeskr Laeger (1999) 1.38
[Sumatriptan (Imigran) to patients with hemiplegic migraine?]. Ugeskr Laeger (1992) 1.38
Pressure-sensitive devices. Pain (1995) 1.38
[Decreased pain threshold and tolerance in patients with chronic tension headache]. Ugeskr Laeger (1997) 1.38
Resource allocation to brain research in Europe (RABRE). Eur J Neurosci (2006) 1.34
A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain (2002) 1.34
Evidence of a genetic factor in migraine with aura: a population-based Danish twin study. Ann Neurol (1999) 1.33
Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain (1989) 1.31
A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry (1996) 1.27
Quantitative evaluation of normal and pathologic cerebral blood flow regulation to perfusion pressure. Changes in man. Arch Neurol (1973) 1.25
Sporadic hemiplegic migraine. Cephalalgia (2004) 1.25
Automatic segmentation and plaque characterization in atherosclerotic carotid artery MR images. MAGMA (2004) 1.24
Right ventricular diastolic function in children with pulmonary regurgitation after repair of tetralogy of Fallot: volumetric evaluation by magnetic resonance velocity mapping. J Am Coll Cardiol (1996) 1.23
Assessment of demyelination, edema, and gliosis by in vivo determination of T1 and T2 in the brain of patients with acute attack of multiple sclerosis. Magn Reson Med (1989) 1.23
Detection and quantification of dysfunctional myocardium by magnetic resonance imaging. A new three-dimensional method for quantitative wall-thickening analysis. Circulation (1997) 1.22
Generalized hyperalgesia in patients with chronic tension-type headache. Cephalalgia (2006) 1.20
Regional cerebral blood flow during migraine attacks by Xenon-133 inhalation and emission tomography. Brain (1984) 1.20
The effects of PaCO2 on regional cerebral blood flow and internal carotid arterial pressure during carotid clamping. Anesthesiology (1971) 1.18
The relative role of genetic and environmental factors in migraine without aura. Neurology (1999) 1.17
Inheritance of migraine investigated by complex segregation analysis. Hum Genet (1995) 1.16
Efficacy of multidisciplinary treatment in a tertiary referral headache centre. Cephalalgia (2005) 1.16
Screening for migraine in the general population: validation of a simple questionnaire. Cephalalgia (1998) 1.16
In vivo quantification of carotid artery wall dimensions: 3.0-Tesla MRI versus B-mode ultrasound imaging. Circ Cardiovasc Imaging (2009) 1.16
Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura. Cephalalgia (1999) 1.15
Leao's spreading depression in the hippocampus explains transient global amnesia. A hypothesis. Acta Neurol Scand (1986) 1.15
MRI-derived left ventricular function parameters and mass in healthy young adults: relation with gender and body size. Int J Card Imaging (1999) 1.13
Pressure-pain threshold in human temporal region. Evaluation of a new pressure algometer. Pain (1986) 1.13
Contralateral focal increase of cerebral blood flow in man during arm work. Brain (1971) 1.13
Analgesic headache. BMJ (1995) 1.13
Noninvasive evaluation of aortocoronary bypass grafts with magnetic resonance flow mapping. Am J Cardiol (1995) 1.12
The Copenhagen Acute Headache Clinic: organization, patient material and treatment results. Headache (1979) 1.12
Pericranial tenderness in tension headache. A blind, controlled study. Cephalalgia (1987) 1.11
Migraine without aura and migraine with aura are inherited disorders. Cephalalgia (1996) 1.11
A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks. Eur J Neurol (1994) 1.10
Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks. Pain (2000) 1.09
Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study. Neurology (1994) 1.09
Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia (2008) 1.09
Some clinical features of the acute migraine attack. An analysis of 750 patients. Headache (1978) 1.09
Classification of primary headaches. Neurology (2004) 1.08
In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis. Magn Reson Med (1988) 1.08
Cerebral oxygen extraction, oxygen consumption, and regional cerebral blood flow during the aura phase of migraine. Stroke (1994) 1.08
Gadolinium contrast-enhanced three-dimensional MRA of peripheral arteries with multiple bolus injection: scan optimization in vitro and in vivo. Int J Card Imaging (1999) 1.08
Biventricular systolic function and mass studied with MR imaging in children with pulmonary regurgitation after repair for tetralogy of Fallot. Radiology (1996) 1.08
Sumatriptan is a potent vasoconstrictor of human dural arteries via a 5-HT1-like receptor. Cephalalgia (1992) 1.07
Migraine without aura: a population-based twin study. Ann Neurol (1999) 1.06